On July 10, 2024, the company announced that its two, major investors, Michal Lach and Robert Dziublowski, had significantly increased their involvement in NanoGroup S.A.
Robert Dziublowski doubled the number of shares he owns and shares in the company, and Michal Lach increased his involvement more than two and a half times. They now have a total of more than 20% in their hands!
The funds raised by the Company as part of the completed increase in the share capital of NanoGroup S.A. will be used for the development of the Company’s main areas of activity, i.e. a comprehensive proprietary system (device and liquid) for extracorporeal storage, as well as regeneration of organs for transplantation (NanOX project), being developed by NanoSanguis S.A., and a proprietary nanoparticle platform including polysaccharide nanoparticles at NanoVelos S.A.
– We are pleased to have the support of such serious investors. Their trust is extremely important to us and – in my opinion – shows that as a company, we are a reliable business partner – says NanoGroup S.A. CEO. Przemysław Mazurek.